PERITONEAL CARCINOMATOSIS
Clinical trials for PERITONEAL CARCINOMATOSIS explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL CARCINOMATOSIS trials appear
Sign up with your email to follow new studies for PERITONEAL CARCINOMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heated chemo during surgery shows promise for rare, deadly adrenal cancer
Disease control OngoingThis study tests a treatment for a rare and aggressive adrenal cancer that has spread to the lining of the abdomen. About 30 people will have surgery to remove all visible tumors, followed by heated chemotherapy (HIPEC) delivered directly into the abdomen. The goal is to see if t…
Matched conditions: PERITONEAL CARCINOMATOSIS
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated May 26, 2026 05:07 UTC
-
Experimental immune therapy takes on Hard-to-Treat cancers
Disease control OngoingThis early-stage trial tests an experimental drug called IMP321, which aims to boost the immune system's ability to fight cancer. It is given in new ways, such as direct injection into tumors or into the abdomen, and combined with other cancer treatments. The study includes 83 ad…
Matched conditions: PERITONEAL CARCINOMATOSIS
Phase: PHASE1 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
New spray chemo combo shows promise for rare abdominal cancer
Disease control TerminatedThis study tests whether adding a special type of chemotherapy called PIPAC (sprayed directly into the abdomen) to standard IV chemotherapy can help people with peritoneal mesothelioma live longer. The trial includes 66 adults who have not had prior treatment and cannot have surg…
Matched conditions: PERITONEAL CARCINOMATOSIS
Phase: PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated May 26, 2026 05:00 UTC
-
New hope for advanced colorectal cancer: does adding chemo to surgery improve survival?
Disease control OngoingThis study tests whether giving chemotherapy before and after surgery (plus heated chemotherapy during surgery) helps people with colorectal cancer that has spread to the abdomen lining live longer compared to surgery alone. About 358 adults with resectable cancer will be randoml…
Matched conditions: PERITONEAL CARCINOMATOSIS
Phase: PHASE2, PHASE3 • Sponsor: Koen Rovers • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New chemo combo targets stomach cancer in the belly
Disease control OngoingThis study tests a treatment for stomach cancer that has spread to the lining of the abdomen. It combines standard chemotherapy given through a vein with chemotherapy delivered directly into the belly. The goal is to see if this approach helps control the cancer and improves surv…
Matched conditions: PERITONEAL CARCINOMATOSIS
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New way to deliver chemotherapy shows promise for stomach cancer patients
Disease control OngoingThis early-phase trial is testing the safety and best dose of the chemotherapy drug paclitaxel when given directly into the abdomen (intraperitoneal) for people with advanced stomach or gastroesophageal cancer that has spread to the lining of the abdomen. The study includes 27 pa…
Matched conditions: PERITONEAL CARCINOMATOSIS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New blood test aims to track stomach and colon cancer spread
Knowledge-focused TerminatedThis study is creating a custom blood test for each person to detect cancer DNA in the blood. It includes 30 patients with gastrointestinal cancer that has spread to the lining of the abdomen. The goal is to see if this test can help guide treatment and monitor cancer over time.
Matched conditions: PERITONEAL CARCINOMATOSIS
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated May 26, 2026 04:59 UTC